Gastro-oesophageal reflux

Published on 23/06/2015 by admin

Filed under Emergency Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1085 times

7.3 Gastro-oesophageal reflux

History

The cardinal symptom of GOR is visible regurgitation of milk post-feeds. This is usually called vomiting, although in GOR the expulsion of gastric contents is generally by an effortless spill, whereas true vomiting involves forceful contraction of abdominal wall musculature. In GOR, the regurgitation is not particularly forceful and the milk usually soils the child’s clothing. Likewise, the physiological ‘posseting’ of milk, which is common after feeding, usually just spills onto the child’s chin region. This is in contrast to the more projectile vomiting of pyloric stenosis, where the milk often propels to a more distant location.

The history is crucial in considering potential differential diagnoses and in identifying complications. Careful questioning regarding the relationship of vomiting to feeds, the content of regurgitated material (e.g. is there blood or bile?), apparent associated distress, and feeding behaviour, is essential. Episodic irritability related to feeds may indicate GOR, although the association between irritability and GOR in infants is generally weak. Atopic features such as eczema and a family history raise the possibility of cows’ milk protein allergy. A history of associated fever suggests an infective cause. Seizures and poor feeding raise the possibility of a metabolic or neurological disorder. Inquiry about associated symptoms such as poor weight gain and respiratory symptoms including apnoea, or wheezing is important to screen for potential complications. Onset of vomiting after 6 months of age is unusual in GOR and suggests an alternative cause.

Differential diagnosis

There are many causes of vomiting in children, and it is important to consider a number of alternative causes that may mimic GOR (see Chapter 7.8 on Diarrhoea and vomiting). These include: infection, e.g. urinary tract infection, gastroenteritis; surgical conditions, e.g. malrotation and volvulus, pyloric stenosis, intussusception; metabolic disorders, e.g. inborn errors, diabetes; food allergy and raised intracranial pressure, e.g. hydrocephalus, posterior fossa tumour, subdural haematoma (Table 7.3.1).

Table 7.3.1 Differential diagnosis of GOR

Urinary tract infection Gastroenteritis Surgical: volvulus, PS, intussusception Food allergy Neurological Metabolic: inborn errors Raised intracranial pressure

Complications

GOR may result in serious complications and is then referred to as GORD.

Respiratory

A number of respiratory complications may occur with GOR. Recurrent aspiration (often silent) results in chronic wheeze or cough, and alveolar disease may develop, with signs of tachypnoea and increased work of breathing. Exposure of the oesophageal mucosa to acid can trigger reflex bronchospasm, and persistent asthma symptoms may occasionally be related to GOR.2 Intermittent (or even isolated) episodes of aspiration can cause pneumonia. Reflux of gastric contents into the upper airway can result in laryngospasm, presenting as an obstructive apnoea or apparent life-threatening event (ALTE).3 However, it is unusual to be able to demonstrate an association between GOR and ALTE.

Investigations

In the majority of cases, a careful history and examination will clarify the likely diagnosis of GOR. Investigations may be required to exclude differential diagnoses, when the diagnosis is unclear.

Serum biochemistry including an acid base, to exclude the evolving metabolic hypokalaemic, hypochloraemic alkalosis of pyloric stenosis, and urine microscopy and culture to screen for a UTI, are relevant first-line tests in the vomiting infant. If the history or biochemistry is suggestive, a pyloric ultrasound should be performed to rule out pyloric stenosis.

Well and thriving infants and children with uncomplicated GOR should not be subjected to any investigations. There are a number of investigations that may be helpful in selected clinical situations. However, the interpretation of studies of oesophageal function and their clinical relevance is not straightforward.

Some children may require admission under a paediatrician for observation of feeding and the presence of regurgitation and consideration of further tests to clarify the diagnosis.

Barium meal and follow through is used to exclude anatomical problems such as malrotation of the small bowel. The observation of GOR merely demonstrates that the infant experienced an episode of reflux at the time of the study. The frequency of GOR episodes, their correlation with clinical symptoms, or the presence of complications cannot be determined from a barium study.

Oesophageal pH monitoring over 24 hours provides representative data about the pH at the lower oesophageal mucosa. A number of indices can be calculated from the monitoring: the frequency of GOR episodes; the length of episodes; and the reflux index – the proportion of time sampled that the oesophageal pH was less than 4 (exposure to gastric acid greater than 10% is usually considered abnormal). However, the association of GOR with oesophagitis is not strong. Infants often have abnormal oesophageal pH findings in the absence of histological features of oesophagitis and, conversely, infants with oesophagitis may have no evidence of significant GOR on pH study.4 These infants presumably have an alternative cause for their oesophagitis, such as allergy. The precise role of oesophageal pH studies is contentious. It is a good test to confirm severe GOR prior to embarking on antireflux surgery, and there may be other clinical scenarios where it provides useful information, e.g. in conjunction with monitoring of respiratory rate, heart rate and oxygen saturations in investigation of apnoea or episodic hypoxaemia/bradycardia.

Oesophagoscopy and biopsy may be indicated for evaluating the presence and severity of oesophagitis, as well as to characterise the changes histologically, e.g. peptic, eosinophilic (allergic), Crohn’s disease, Barrett’s oesophagus.

Aspiration of gastric contents into the lungs can be identified by nuclear medicine study using radiolabelled milk (can detect aspiration events up to 24 hours following a feed). A chest X-ray ± computerised tomography scan of the chest can be used to evaluate for chronic lung disease.

Treatment

Children diagnosed with GOR need follow up organised with the local doctor, to ensure no alternative diagnosis is missed and to monitor for complications. Parents need an explanation of the symptoms and to be reassured that the natural history is for spontaneous resolution over months. It is unusual for GOR symptoms to persist beyond 12 to 15 months of age. If there is any doubt about the diagnosis, then a paediatric review should be arranged.

Simple measures

A number of conservative measures are commonly used to reduce the symptoms of GOR. These include posturing (elevation of cot ~30 degrees head up), thickening of feeds,5 and changes to infant formulas. None of these have been demonstrated to modify clinical outcomes.6 A trial of a partially hydrolysed formula may be indicated in GORD, e.g. GOR with failure to thrive. Prone sleeping position is best for reducing GOR7 but is not generally recommended as it as associated with sudden infant death syndrome. Suggesting positioning a towel on the carer’s shoulder may decrease the inconvenience of refluxed milk onto the parent during feeding.

Pharmacological

Pharmacological treatment of otherwise well, thriving infants with uncomplicated benign GOR is not indicated.8

In more severe cases, the pharmacological options include antacids, antisecretory therapies, and prokinetic agents. High-dose antacids can be effective in treating oesophagitis.9 However, prolonged use can be associated with aluminium toxicity and is not recommended. H2-receptor antagonists such as ranitidine have been shown to improve both histological changes and symptoms.10 Proton pump inhibitors have well-demonstrated clinical efficacy in children with reflux oesophagitis11,12 and appear to be safe. Prokinetic agents do not have clear evidence for symptom reduction;13 however, a trial of domperidone or erythromycin may be worthwhile in GORD.

References

1 Campanozzi A., Boccia G., Pensabene L., et al. Prevalence and natural history of gastroesophageal reflux: pediatric prospective survey. Pediatrics. 2009;123:779.

2 Balson B.M., Kravitz E.K., McGeady S.J. Diagnosis and treatment of gastroesophageal reflux in children and adolescents with severe asthma. Ann Allergy Asthma Immunol. 1998;81:159-164.

3 Menon A.P., Schefft G.L., Thach B.T. Apnea associated with regurgitation in infants. J Pediatr. 1985;106:625-629.

4 Heine R.G., Cameron D.J.S., Chow C.W., et al. Esophagitis in distressed infants: Poor diagnostic agreement between esophageal pH monitoring and histopathologic findings. J Pediatr. 2002;140:14-19.

5 Horvath A., Dziechciarz P., Szajewska H. The effect of thickened-feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized controlled trials. Pediatrics. 2008;122:e1268.

6 Carroll A.E., Garrison M.M., Christakis D.A. A systematic review of nonpharmacological and nonsurgical therapies for gastroesophageal reflux in infants. Arch Pediatr Adolesc Med. 2002;156:109-113.

7 Meyers W.F., Herbst J.J. Effectiveness of positioning therapy for gastroesophageal reflux. Paediatrics. 1982;69:768-782.

8 Khoshoo V., Edell D., Thompson A., Rubin M. Are we overprescribing antireflux medications for infants with regurgitation? Pediatrics. 2007;120:946.

9 Cucchiara S., Staniano A., Romaniello G., et al. Antacids and cimetidine treatment for gastroesophageal reflux and peptic oesophagitis. Arch Dis Child. 1984;59:842-847.

10 Simeone D., Caria M.C., Miele E., et al. Treatment of childhood peptic oesophagitis: A double-blind placebo-controlled trial of nizatidine. J Pediatr Gastroenterol Nutr. 1997;25:51-55.

11 Kato S., Ebina K., Fujii K., et al. Effect of omeprazole in the treatment of refactory acid-related diseases in childhood: Endoscopic healing and twenty-four hour intragastric acidity. J Pediatr. 1996;128:415-421.

12 DeGiacomo C., Bawa P., Franceschi M., et al. Omeprazole for severe gastroesophageal reflux in children. J Pediatr Gastroenterol Nutr. 1997;24:528-532.

13 Augood C., MacLennan S., Gilbert R., Logan S. Cisapride treatment for gastro-oesophageal reflux in children (Cochrane Review). In: The Cochrane Library. Chichester: John Wiley & Sons; 2002. Issue 4